MYOVANT SCIENCES
LIVE

Serial Number

88254868

Owner

Myovant Sciences GmbH

Attorney

Joyce M. Ferraro

Filing Date

Jan 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MYOVANT SCIENCES Trademark

Serial Number: 88254868 • Registration: 5987696

MYOVANT SCIENCES is a trademark filed by Myovant Sciences GmbH on January 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Myovant Sciences GmbH (31 trademarks)

Basel 4051 , CH

Entity Type: 99

SUMITOMO PHARMA SWITZERLAND GMBH (15 trademarks)

AESCHENGRABEN 27
BASEL 4051 , CH

Entity Type: 27

Trademark Details

Filing Date

January 9, 2019

Registration Date

February 18, 2020

Published for Opposition

December 3, 2019

Goods & Services

Pharmaceutical preparations for human use for the treatment of prostate cancer, of oncological, endocrinological, and hormonal diseases, disorders and conditions, and of women's health diseases, disorders and conditions in the nature of gynecological, obstetric, and breast diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of prostate cancer, of oncological, endocrinological, and hormonal diseases, disorders and conditions, and of women's health diseases, disorders and conditions in the nature of gynecological, obstetric, and breast diseases, disorders and conditions

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis, and technological consulting in the fields of pharmaceuticals, biomedicine, clinical trials for others and post-market trials for others; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials for others and post-market trials for others; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 18, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 13, 2023 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 26, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 26, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 26, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 26, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 26, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2019 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Mar 29, 2019 CEPE
ASSIGNED TO LIE
Mar 29, 2019 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 28, 2019 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 28, 2019 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 28, 2019 CPEA
ASSIGNED TO EXAMINER
Mar 25, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2019 NWOS
NEW APPLICATION ENTERED
Jan 12, 2019 NWAP